Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04845906 · ClinicalTrials.gov registry record
A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices
A clinical trial of Peripheral Intravenous Catheter Stabilization, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- 120
- Enrollment target
- 2
- Study locations
NCT04845906: Completed study of Peripheral Intravenous Catheter Stabilization, sponsored by Becton, Dickinson and Company.
NCT04845906 is a study of Peripheral Intravenous Catheter Stabilization that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 120 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04845906, a study of Peripheral Intravenous Catheter Stabilization, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a prospective healthy human volunteer wear study to evaluate the safety and performance of the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device Accessory (Foam Strip) and to meet the design input requirements.
Primary Outcome
Device pad lift will be assessed using a Visual Analog Scale, ranging from 0 - Fully adhered to 100 - Device absent. When the percent lift at day 7 is \>50%, it is considered a failure.
Conditions Studied
Interventions
- DEVICE StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip)
Study Locations (2)
New Jersey
- TKL Research, Inc - Fair Lawn
Pennsylvania
- Dermico, LLC - Broomall
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-07-13 |
| Est. Completion | 2021-08-23 |
What the finished NCT04845906 record still lists
NCT04845906 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Peripheral Intravenous Catheter Stabilization appearing as the primary indexed condition, and to 1 intervention - of which StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip) is the first listed.
NCT04845906 reports a single indexed study location in New Jersey, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04845906 about?
NCT04845906 is a clinical study titled "A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices". This study is a prospective healthy human volunteer wear study to evaluate the safety and performance of the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device Accessory (Foam Strip) and to meet the design input requirements.
What is the current status of trial NCT04845906?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2021-07-13. Estimated completion is 2021-08-23.
What conditions does trial NCT04845906 study?
This clinical trial studies the following conditions: Peripheral Intravenous Catheter Stabilization.
What interventions are being tested in trial NCT04845906?
The interventions under investigation include: StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip) (DEVICE).
Who is sponsoring clinical trial NCT04845906?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04845906 being conducted?
This trial has 2 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI